NCT06940011View on ClinicalTrials.gov

Endocalyx in Treatment Resistent Hypertension

PHASE2RecruitingINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

January 21, 2025

Primary Completion Date

December 1, 2027

Study Completion Date

January 1, 2028

Conditions
Treatment Resistant Hypertension
Interventions
DIETARY_SUPPLEMENT

Endocalyx Pro

4 capsules once daily OR 2 capsules twice daily

OTHER

Placebo

4 capsules once daily OR 2 capsules twice daily

Trial Locations (1)

1105 AZ

RECRUITING

Amsterdam UMC, Amsterdam

Sponsors
All Listed Sponsors
collaborator

Dutch Heart Foundation

OTHER

collaborator

Dutch Kidney Foundation

OTHER

collaborator

Microvascular Health Solutions LLC

UNKNOWN

lead

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

OTHER